Project description
Ending endometriosis diagnostic delay
One of the most common chronic diseases in fertile women, endometriosis affects 14 million women across the EU. The disease is caused by tissue from the uterus growing mainly in the lower abdomen. The most common symptoms are intense pain during periods and intercourse, and chronic pelvic pain. However, it takes years for the disease to be correctly diagnosed, and sufferers are at greater risk of ovarian cancer than the rest of the female population. The EU-funded TRENDO project will address the main problems in endometriosis diagnosis and therapy. Bringing together clinical and translational science experts and industry partners from six European and South American countries, the project will develop non-invasive biomarkers and testing, which will shorten diagnostic delay and reduce unequal access to expensive healthcare.
Call for proposal
H2020-MSCA-RISE-2020
See other projects for this call
Funding Scheme
MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)Coordinator
48149 Muenster
Germany
Participants (7)
17177 Stockholm
50411 Tartu
6200 MD Maastricht
02 091 Warszawa
1000 Ljubljana
48149 Munster
12618 Tallinn
Partners (1)
C1425FQB Buenos Aires